Stock Events

Stock Events

Novartis 

$160.84
2332
-$2.84-1.74% 18:04 Today

Statistics

Day High
156.89
Day Low
156.89
52W High
171.29
52W Low
118.02
Volume
1
Avg. Volume
20,463
Mkt Cap
305.71B
P/E Ratio
22.01
Dividend Yield
2.88%
Dividend
4.63

Upcoming

Dividends

2.88%Dividend Yield
Mar 26
$4.71
Mar 25
$3.96
Mar 24
$3.76
Mar 23
$3.51
Mar 22
$3.34
10Y Growth
5.7%
5Y Growth
8.01%
3Y Growth
10.34%
1Y Growth
18.82%

Earnings

27OctExpected
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Next
1.99
2.13
2.28
2.42
Expected EPS
2.226874
Actual EPS
N/A

Financials

24.67%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
56.67BRevenue
13.98BNet Income

Analyst Ratings

170.00Average Price Target
The highest estimate is 170.00.
From 1 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow NVSEF. It's not an investment recommendation.
Microsoft
381
MSFT
Coca-Cola
353
KO
Apple
323
AAPL
Realty Income
322
O

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap159.36B
Pfizer competes directly with Novartis in various therapeutic areas, including cardiovascular, oncology, and immunology.
Johnson & Johnson
JNJ
Mkt Cap645.95B
Johnson & Johnson, through its pharmaceutical segment, competes in areas such as immunology and oncology, similar to Novartis.
Merck
MRK
Mkt Cap366B
Merck is a key competitor in the oncology sector, directly competing with Novartis' cancer treatments.
Roche
RHHBY
Mkt Cap334.28B
Roche competes closely with Novartis, especially in oncology and ophthalmology, with both companies headquartered in Switzerland.
Abbvie
ABBV
Mkt Cap451.46B
AbbVie competes in the immunology and oncology markets, areas where Novartis has significant investments.
GSK
GSK
Mkt Cap101.78B
GlaxoSmithKline competes with Novartis in respiratory, vaccines, and HIV, areas where Novartis has presence or interest.
Bristol-Myers Squibb
BMY
Mkt Cap136B
Bristol Myers Squibb is a competitor in the oncology and cardiovascular markets, directly competing with Novartis' drug portfolio.
Sanofi
SNY
Mkt Cap107.39B
Sanofi competes with Novartis in areas such as vaccines, oncology, and cardiovascular diseases.
Astrazeneca
AZN
Mkt Cap252.33B
AstraZeneca competes in the oncology, cardiovascular, and respiratory sectors, overlapping with Novartis' interests.
AMGEN
AMGN
Mkt Cap233.78B
Amgen competes with Novartis in the biopharmaceutical sector, particularly in treatments for bone diseases, cancer, and cardiovascular diseases.

About

Novartis develops and manufactures innovative drugs. Key areas of drug development are oncology, immunology, neuroscience, and cardiovascular, renal, and metabolic. It also has an established medicines business, which includes off-patent franchises. The company sells its products globally, with the United States constituting close to one-third of total revenue.
Show more...
CEO
Vas Narasimhan
Employees
75267
Country
Switzerland
ISIN
CH0012005267
WKN
000904278

Listings

MX
MX
NOVNN.MX
NEO
CA
NOVN.NEO
STU
DE
NOT.STU
F
DE
NOT0.F

0 Comments

Share your thoughts

FAQ

What is Novartis stock price today?▼
The current price of NVSEF is $160.84 USD — it has decreased by -1.74% in the past 24 hours. Watch Novartis stock price performance more closely on the chart.
What is Novartis stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Novartis stocks are traded under the ticker NVSEF.
Is Novartis stock price growing?▼
NVSEF stock has fallen by -3.38% compared to the previous week, the month change is a +1.87% rise, over the last year Novartis has showed a +21.6% increase.
What is Novartis market cap?▼
Today Novartis has the market capitalization of 305.71B
When is the next Novartis earnings date?▼
Novartis is going to release the next earnings report on October 27, 2026.
What were Novartis earnings last quarter?▼
NVSEF earnings for the last quarter are 2.41 USD per share, whereas the estimation was 2.17 USD resulting in a +11.17% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Novartis revenue for the last year?▼
Novartis revenue for the last year amounts to 56.67B USD.
What is Novartis net income for the last year?▼
NVSEF net income for the last year is 13.98B USD.
Does Novartis pay dividends?▼
Yes, NVSEF dividends are paid annual. The last dividend per share was 4.71 USD. As of today, Dividend Yield (FWD)% is 2.88%.
How many employees does Novartis have?▼
As of September 04, 2026, the company has 75,267 employees.
In which sector is Novartis located?▼
Novartis operates in the Health & Wellness sector.
When did Novartis complete a stock split?▼
Novartis has not had any recent stock splits.
Where is Novartis headquartered?▼
Novartis is headquartered in Basel, Switzerland.